Metabolomic mapping of atypical antipsychotic effects in schizophrenia

Kaddurah-Daouk, R, McEvoy, J, Baillie, R A, Lee, D, Yao, J K, Doraiswamy, P M, Krishnan, K R R·2007·Molecular Psychiatry

DOI 10.1038/sj.mp.4002000

Cited by (261)

Items 101–200 of 261

Non-targeted metabolite profiling reveals changes in oxidative stress, tryptophan and lipid metabolisms in fearful dogs
Jenni Puurunen, Katriina Tiira, Marko Lehtonen, Kati Hanhineva, Hannes Lohi · 2016 · Behavioral and Brain Functions
Differential effects of antipsychotic medications on polyunsaturated fatty acid biosynthesis in rats: Relationship with liver delta6-desaturase expression
Robert K. McNamara, Ronald J. Jandacek, Therese Rider, Patrick Tso, Allyson Cole-Strauss, Jack W. Lipton · 2011 · Schizophrenia Research
Changes in the blood plasma lipidome associated with effective or poor response to atypical antipsychotic treatments in schizophrenia patients
de Almeida, Valéria, Alexandrino, Guilherme L., Aquino, Adriano, Gomes, Alexandre F., Murgu, Michael, Dobrowolny, Henrik, Guest, Paul C., Steiner, Johann, Martins-de-Souza, Daniel · 2020 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Progress in defining the biological causes of schizophrenia
Ben S. Pickard · 2011 · Expert Reviews in Molecular Medicine
Serum metabolite profile associates with the development of metabolic co-morbidities in first-episode psychosis
Tommi Suvitaival, Outi Mantere, Tuula Kieseppä, Ismo Matias Mattila, Päivi Pöhö, Tuulia Hyötyläinen, Jaana Suvisaari, Matej Orešič · 2016 · Translational Psychiatry
Chronic risperidone treatment preferentially increases rat erythrocyte and prefrontal cortex omega-3 fatty acid composition: Evidence for augmented biosynthesis
Robert K. McNamara, Jessica A. Able, Ronald J. Jandacek, Therese Rider, Patrick Tso · 2008 · Schizophrenia Research
Serum metabolic profiling using small molecular water‐soluble metabolites in individuals with schizophrenia: A longitudinal study using a pre–post‐treatment design
Bing Cao, Min Jin, Elisa Macedo Brietzke, Roger S. McIntyre, Dongfang Wang, Joshua Daniel Rosenblat, Renee‐Marie Ragguett, Chuanbo Zhang, Xiaoyu Sun, Carola Rong et al. · 2018 · Psychiatry and Clinical Neurosciences
Association between antipsychotic-induced metabolic side-effects and clinical improvement: A review on the Evidence for “metabolic threshold”
Eesha Sharma, Naren Prahalada Rao, Ganesan Venkatasubramanian · 2013 · Asian Journal of Psychiatry
Lipidomic Analysis of Biological Samples by Liquid Chromatography Coupled to Mass Spectrometry
Giuseppe Astarita, Faizy Ahmed, Daniele Piomelli · 2009 · Methods in molecular biology
Lipids in Psychiatric Disorders: Functional and Potential Diagnostic Role as Blood Biomarkers
Zorkina, Yana, Ushakova, Valeria, Ochneva, Aleksandra, Tsurina, Anna, Abramova, Olga, Savenkova, Valeria, Goncharova, Anna, Alekseenko, Irina, Morozova, Irina, Riabinina, Daria et al. · 2024 · Metabolites
An Untargeted Metabolomics Analysis of Antipsychotic Use in Bipolar Disorder
Kyle Jon Burghardt, Simon J. Evans, Kristen M. Wiese, Vicki L. Ellingrod · 2015 · Clinical and Translational Science
Gene‐specific DNA methylation may mediate atypical antipsychotic‐induced insulin resistance
Kyle Jon Burghardt, Jaclyn M. Goodrich, Dana C. Dolinoy, Vicki L. Ellingrod · 2016 · Bipolar Disorders
Unbiased Lipidomic Profiling Reveals Metabolomic Changes during the Onset and Antipsychotics Treatment of Schizophrenia Disease
Yan, Lailai, Zhou, Juntuo, Wang, Dongfang, Si, Dandan, Liu, Yaqiong, Zhong, Lijun, Yin, Yuxin · 2018 · Metabolomics
Maternal Malnutrition in the Etiopathogenesis of Psychiatric Diseases: Role of Polyunsaturated Fatty Acids
Maria Grazia Morgese, Luigia Trabace · 2016 · Brain Sciences
Behavioral and Molecular Biomarkers in Translational Animal Models for Neuropsychiatric Disorders
Zóltan Sarnyai, Murtada Alsaif, Sabine Bahn, Agnes Ernst, Paul C. Guest, Eva Hradetzky, Wolfgang F. Kluge, Viktoria Stelzhammer, Hendrik Wesseling · 2011 · International review of neurobiology
Links between central CB1-receptor availability and peripheral endocannabinoids in patients with first episode psychosis
Alex M. Dickens, Faith Borgan, Heikki Laurikainen, Santosh Lamichhane, Tiago Reis Marques, Tuukka Rönkkö, Mattia Veronese, Tuomas Lindeman, METSY Investigators, Tuulia Hyötyläinen et al. · 2020 · Schizophrenia
Reduced erythrocyte membrane polyunsaturated fatty acid levels indicate diminished treatment response in patients with multi- versus first-episode schizophrenia
Nana Li, Ping Yang, Mimi Tang, Yong Hong Liu, Wenbin Guo, Bing Lang, Jianjian Wang, Haishan Wu, Hui Tang, Yan Hua Yu et al. · 2022 · Schizophrenia
Reverting Metabolic Dysfunction in Cortex and Cerebellum of APP/PS1 Mice, a Model for Alzheimer’s Disease by Pioglitazone, a Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Agonist
Kai Lun Chang, Ling Rong Wong, Hai Ning Pee, Shili Yang, Paul C. Ho · 2019 · Molecular Neurobiology
Recent advances in understanding and mitigating adipogenic and metabolic effects of antipsychotic drugs
Julia M. Gohlke · 2012 · Frontiers in Psychiatry
Metabolomic Biomarkers in Mental Disorders: Bipolar Disorder and Schizophrenia
Quintero, Melissa, Stanisic, Danijela, Cruz, Guilherme, Pontes, João G. M., Costa, Tássia Brena Barroso Carneiro, Tasic, Ljubica · 2019 · Advances in Experimental Medicine and Biology
Lipidomics of the brain, retina, and biofluids: from the biological landscape to potential clinical application in schizophrenia
Chuanjun Zhuo, Weihong Hou, Hongjun Tian, Lina Wang, Ranli Li · 2020 · Translational Psychiatry
Metabolomics in pharmacology - a delve into the novel field of pharmacometabolomics
Michele Mussap, Cristina Loddo, Claudia Fanni, Vassilios Fanos · 2020 · Expert Review of Clinical Pharmacology
Membrane fatty acid levels as a predictor of treatment response in chronic schizophrenia
Tomiki Sumiyoshi, Yuko Higuchi, Mié Matsui, Hiroko Itoh, Takashi Uehara, Tôru Itoh, Hirofumi Arai, Chieko Takamiya, Michio Suzuki, Masayoshi Kurachi · 2010 · Psychiatry Research
What Are We Looking for in New Antipsychotics?
Christoph Ulrich Correll · 2011 · The Journal of Clinical Psychiatry
Lipidomics, Biomarkers, and Schizophrenia: A Current Perspective
Sumit Sethi, Mirian A.F. Hayashi, Banny Silva Barbosa Correia, João Guilherme de Moraes Pontes, Ljubica Tasić, Elisa Macedo Brietzke · 2017 · Advances in experimental medicine and biology
Exploring mechanisms of increased cardiovascular disease risk with antipsychotic medications: Risperidone alters the cardiac proteomic signature in mice
Megan Beauchemin, Ramaz Geguchadze, Anyonya R. Guntur, Kathleen T. Nevola, Phuong T. Le, Deborah J. Barlow, Megan Rue, Calvin Vary, Christine W. Lary, Katherine J. Motyl et al. · 2019 · Pharmacological Research
Blood-Based Lipidomics Approach to Evaluate Biomarkers Associated With Response to Olanzapine, Risperidone, and Quetiapine Treatment in Schizophrenia Patients
Adriano Aquino, Guilherme L. Alexandrino, Paul C. Guest, Fábio Augusto, Alexandre F. Gomes, Michael Murgu, Johann Steiner, Daniel Martins‐de‐Souza · 2018 · Frontiers in Psychiatry
Pretreatment levels of the fatty acid handling proteins H-FABP and CD36 predict response to olanzapine in recent-onset schizophrenia patients
Jakub Tomasik, Emanuel Schwarz, Santiago G. Lago, Matthias Rothermundt, F. Markus Leweke, Nico J.M. van Beveren, Paul C. Guest, Hassan Rahmoune, Johann Steiner, Sabine Bahn · 2015 · Brain Behavior and Immunity
Pharmacometabolomics-aided Pharmacogenomics in Autoimmune Disease
Θεοδώρα Κάτσιλα, Evangelia K. Konstantinou, Ioanna Lavda, Harilaos Malakis, Ioanna Papantoni, Lamprini Skondra, George P. Patrinos · 2016 · EBioMedicine
Characterising Phospholipids and Free Fatty Acids in Patients with Schizophrenia: A Case-Control Study
Wang, Dongfang, Sun, Xiaoyu, Maziade, Michel, Mao, Wei, Zhang, Chuanbo, Wang, Jingyu, Cao, Bing · 2021 · The World Journal of Biological Psychiatry
Biomarkers for combat-related PTSD: focus on molecular networks from high-dimensional data
Thomas C. Neylan, Eric E. Schadt, Rachel Yehuda · 2014 · European Journal of Psychotraumatology
Pharmaceutical research and metabolomics in the newborn
Roberto Antonucci, Maria Dolores Pilloni, Luigi Atzori, Vassilios Fanos · 2012 · The Journal of Maternal-Fetal & Neonatal Medicine
Cardiometabolic risk in first-episode schizophrenia (FES) patients with the earliest stages of both illness and antipsychotic treatment
Desheng Zhai, Taizhen Cui, Yahui Xu, Yihang Feng, Xin Wang, Yuxin Yang, Songji Li, Dushuang Zhou, Gaopan Dong, Ying Zhao et al. · 2016 · Schizophrenia Research
Metabolic profiling for water-soluble metabolites in patients with schizophrenia and healthy controls in a Chinese population: A case-control study
Bing Cao, Dongfang Wang, Zihang Pan, Roger S. McIntyre, Elisa Macedo Brietzke, Mehala Subramanieapillai, Yasaman Nozari, Jingyu Wang · 2019 · The World Journal of Biological Psychiatry
Effects of Psychostimulants and Antipsychotics on Serum Lipids in an Animal Model for Schizophrenia
Banny Silva Barbosa Correia, João Victor Silva Nani, Raniery Waladares Ricardo, Danijela Stanišić, Tássia Brena Barroso Carneiro Costa, Mirian A.F. Hayashi, Ljubica Tasić · 2021 · Biomedicines
Phospholipid composition of postmortem schizophrenic brain by 31P NMR spectroscopy
John M. Pearce, Richard A. Komoroski, Robert Emil Mrak · 2008 · Magnetic Resonance in Medicine
Genetic Influence on Efficacy of Pharmacotherapy for Pediatric Attention-Deficit/Hyperactivity Disorder: Overview and Current Status of Research
Elsayed, Nada A., Yamamoto, Kaila M., Froehlich, Tanya E. · 2020 · CNS Drugs
RNA Sequencing Reveals a Slow to Fast Muscle Fiber Type Transition after Olanzapine Infusion in Rats
Christopher J. Lynch, Yuping Xu, András Sándor Hajnal, Anna C. Salzberg, Yuka Imamura Kawasawa · 2015 · PLoS ONE
The search for peripheral disease markers in psychiatry by genomic and proteomic approaches
Enrico Domenici, Pierandrea Muglia · 2007 · Expert Opinion on Medical Diagnostics
Obesity and psychotic disorders: uncovering common mechanisms through metabolomics
Matej Orešič · 2012 · Disease Models & Mechanisms
Identification of cerebrospinal fluid and serum metabolomic biomarkers in first episode psychosis patients
Pei Shang, Ada Man‐Choi Ho, Maximilian Tufvesson‐Alm, Daniel R. Lindberg, Caroline W. Grant, Funda Orhan, Feride Eren, Maria Bhat, Göran Engberg, Lilly Schwieler et al. · 2022 · Translational Psychiatry
Antipsychotic-Induced Alterations in Lipid Turnover
Sandra Pereira, Emily Au, Sri Mahavir Agarwal, David Charles Wright, Margaret Hahn · 2023 · Endocrinology
Metabolomics-based understanding of the olanzapine-induced weight gain in female first-episode drug-naïve patients with schizophrenia
Jia Hong Liu, Nan Chen, Yan Hong Guo, Xiao Ni Guan, Jun Wang, Dong Wang, Mei Hong Xiu · 2021 · Journal of Psychiatric Research
Phospholipid membrane abnormalities and reduced niacin skin flush response in schizophrenia.
Alena Buretić‐Tomljanović, Jasminka Giacometti, Sergej Nadalin, Gordana Rubeša, Mirjana Vulin, Draško Tomljanović · 2008 · PubMed
Chronic clozapine reduces rat brain arachidonic acid metabolism by reducing plasma arachidonic acid availability
Hiren R. Modi, Ameer Y. Taha, Hyung‐Wook Kim, Lisa Chang, Stanley Isaac Rapoport, Yewon Cheon · 2012 · Journal of Neurochemistry
Precision medicine for psychopharmacology: a general introduction
Cheolmin Shin, Changsu Han, Chi‐Un Pae, Ashwin A. Patkar · 2016 · Expert Review of Neurotherapeutics
Plasma Lysophosphatidylcholine and Lysophosphatidylethanolamine Levels Were Associated With the Therapeutic Response to Olanzapine in Female Antipsychotics-naïve First-episode Patients With Schizophrenia
Jiahong Liu, Meihong Xiu, Haixia Liu, Jun Wang, Xirong Li · 2021 · Frontiers in Pharmacology
Antipsychotic Drug Effects on Left Prefrontal Phospholipid Metabolism: A Follow-up 31P-2D-CSI Study of Haloperidol and Risperidone in Acutely Ill Chronic Schizophrenia Patients
Smesny, Stefan, Langbein, Kerstin, Rzanny, Reinhardt, Gussew, Alexander, Burmeister, Hartmut P., Reichenbach, Juergen R., Sauer, Heinrich · 2012 · Schizophrenia Research
Organizational Improvements to Enhance Modern Clinical Epidemiology
Robert M. Califf · 2008 · JAMA
The role of metabolomics in precision medicine
Soumeya Bekri · 2016 · Expert Review of Precision Medicine and Drug Development
Identifying individual differences of fluoxetine response in juvenile rhesus monkeys by metabolite profiling
Ying He, Casey E. Hogrefe, Dmitry Grapov, Mine Palazoglu, Oliver Fiehn, Christoph W. Turck, Mari S. Golub · 2014 · Translational Psychiatry
Access to the CNS: Biomarker Strategies for Dopaminergic Treatments
Willem Johan van den Brink, Semra Palić, Isabelle Köhler, Elizabeth C. M. de Lange · 2018 · Pharmaceutical Research
Plasma amino acids profile in first-episode psychosis, unaffected siblings and community-based controls
Camila Marcelino Loureiro, Daiane Leite da Roza, Fabiana Maria das Graças Corsi Zuelli, Rosana Shuhama, Helene Fachim, Lívia M.C. Simões-Ambrósio, Rafael Deminice, Alceu Afonso Jordão, Paulo Rossi Menezes, Cristina Marta Del‐Ben et al. · 2020 · Scientific Reports
Current State of Fluid Lipid Biomarkers for Personalized Diagnostics and Therapeutics in Schizophrenia Spectrum Disorders and Related Psychoses: A Narrative Review
Timothy A. Couttas, Beverly Jieu, Cathrin Rohleder, F. Markus Leweke · 2022 · Frontiers in Psychiatry
Metabolomics, Lipidomics, and Antipsychotics: A Systematic Review
Kyle Jon Burghardt, Megan Kajy, Kristen M. Ward, Paul Ryen Burghardt · 2023 · Biomedicines
Dysregulation of Serum Exosomal Lipid Metabolism in Schizophrenia: A Biomarker Perspective
Chen-Xi Xu, Wei Huang, Xiaojie Shi, Yang Du, Jiaquan Liang, Xuan Fang, He-Yuan Chen, Yong Cheng · 2024 · Molecular Neurobiology
Plasma metabonomics study of first-Episode schizophrenia treated with olanzapine in female patients
Ying Qiao, Lei Zhang, Shen He, Hui Wen, Yimin Yu, Chun-Hua Cao, Huafang Li · 2016 · Neuroscience Letters
Platform for systems medicine research and diagnostic applications in psychotic disorders—The METSY project
Elisabeth Frank, Dieter Maier, Juha Pajula, Tommi Suvitaival, Faith Borgan, Markus Butz‐Ostendorf, Alexander Fischer, Jarmo A. Hietala, Oliver David Howes, Tuulia Hyötyläinen et al. · 2018 · European Psychiatry
Pharmacotherapy of schizophrenia: toward a metabolomic-based approach
Haythum Osama Tayeb, Hussam A. S. Murad, Misbahuddin M. Rafeeq, Frank I. Tarazi · 2018 · CNS Spectrums
Metabolomic strategies to identify tissue-specific effects of cardiovascular drugs
Minna T. Jänis, Reijo Laaksonen, Matej Orešič · 2008 · Expert Opinion on Drug Metabolism & Toxicology
Drug Class Review: Atypical Antipsychotic Drugs
Marian S. McDonagh, Kim Peterson, Susan Carson, Rochelle Fu, Sujata Thakurta · 2010
Application of fatty acid and lipid measurements in neuropsychiatry
Agatha Grela, Wojciech Rachel, Michael Cole, Tomasz Zyss, Andrzej Zięba, Wojciech Piekoszewski · 2015 · Clinical Chemistry and Laboratory Medicine (CCLM)
Use of Genome-Wide High-Throughput Technologies in Biomarker Development
Sabine Claßen, Andrea Staratschek‐Jox, Joachim Ludwig Schultze · 2008 · Biomarkers in Medicine
Multivariate pharmacokinetic/pharmacodynamic (PKPD) analysis with metabolomics shows multiple effects of remoxipride in rats
W.J. van den Brink, Jeroen Elassaiss‐Schaap, Belén Gonzalez‐Amoros, Amy C. Harms, Piet H. van der Graaf, Thomas Hankemeier, Elizabeth C. M. de Lange · 2017 · European Journal of Pharmaceutical Sciences
Pharmacometabolomic Signature of Ataxia SCA1 Mouse Model and Lithium Effects
Bertrand Perroud, Paymaan Jafar‐Nejad, William R. Wikoff, Jennifer R. Gatchel, Lu Wang, Dinesh Kumar Barupal, Juan Crespo-Barreto, Oliver Fiehn, Huda Yahya Zoghbi, Rima Kaddurah‐Daouk · 2013 · PLoS ONE
Frontiers in metabolomics for cancer research: Proceedings of a National Cancer Institute workshop
Young Shin Kim, Padma Maruvada · 2008 · Metabolomics
Macrophage-derived secretome is sufficient to confer olanzapine-mediated insulin resistance in human adipocytes
Priya Dipta, Assel Sarsenbayeva, Miriam Shmuel, Francesca Forno, Jan W. Eriksson, Maria J. Pereira, Xesús Manoel Abalo, Martin Wabitsch, Morten Thaysen‐Andersen, Boaz Tirosh · 2021 · Comprehensive Psychoneuroendocrinology
Metabonomic Studies of Schizophrenia and Psychotropic Medications: Focus on Alterations in CNS Energy Homeostasis
Dan Ma, Paul C. Guest, Sabine Bahn · 2009 · Bioanalysis
Biomarkers for Antipsychotic Therapies
Emilio Merlo Pich, Gabriel A. Vargas, Enrico Domenici · 2012 · Handbook of experimental pharmacology
Identification of Plasma Biomarkers in Drug-Naïve Schizophrenia Using Targeted Metabolomics
Qiao Su, Fuyou Bi, Shu Yang, Huiming Yan, Xiaoxiao Sun, Jiayue Wang, Yuying Qiu, Meijuan Li, Shen Li, Jie Li · 2023 · Psychiatry Investigation
The Antipsychotic Risperidone Alters Dihydroceramide and Ceramide Composition and Plasma Membrane Function in Leukocytes In Vitro and In Vivo
Canfrán-Duque, Alberto, Pastor, Óscar, García-Seisdedos, David, Molina, Yessenia L., Babiy, Bohdan, Lerma, Milagros, Sánchez-Castellano, Carmen, Martínez-Botas, Javier, Gómez-Coronado, Diego, Lasunción, Miguel A. et al. · 2021 · International Journal of Molecular Sciences
Serum Metabolic Profile in Schizophrenia Patients With Antipsychotic-Induced Constipation and Its relationship With Gut Microbiome
Nousayhah Amdanee, Miaomiao Shao, Xiuxiu Hu, Xinyu Fang, Chao Zhou, Jiu Chen, Mohammad Ridwan Chattun, Lu Wen, Xinming Pan, Xiangrong Zhang et al. · 2023 · Schizophrenia Bulletin
A targeted neurotransmitter quantification and nontargeted metabolic profiling method for pharmacometabolomics analysis of olanzapine by using UPLC-HRMS
Dan Liu, Zhuoling An, Pengfei Li, Yanhua Chen, Ruiping Zhang, Lihong Liu, Jiuming He, Zeper Abliz · 2020 · RSC Advances
Altered lipidomics biosignatures in schizophrenia: A systematic review
Alexandros Messinis, Eirini Panteli, Aristea Paraskevopoulou, Aikaterini-Kerasia Zymarikopoulou, Michaela D. Filiou · 2024 · Schizophrenia Research
Peripheral Lipid Signatures, Metabolic Dysfunction, and Pathophysiology in Schizophrenia Spectrum Disorders
Sally Wu, Kristoffer J. Panganiban, Jiwon Lee, Dan Li, Emily C. C. Smith, Kateryna Maksyutynska, Bailey E. Humber, Tariq Ahmed, Sri Mahavir Agarwal, Kristen M. Ward et al. · 2024 · Metabolites
Bundling arrows: improving translational CNS drug development by integrated PK/PD-metabolomics
W. J. van den Brink, Thomas Hankemeier, Piet H. van der Graaf, Elizabeth C. M. de Lange · 2018 · Expert Opinion on Drug Discovery
Pharmacometabolomics: A New Horizon in Personalized Medicine
Abdul-Hamid M. Emwas, Kacper Szczepski, Ryan T. McKay, Hiba Nabil Asfour, Chung‐ke Chang, Joanna Izabela Lachowicz, Mariusz Jaremko · 2021 · IntechOpen eBooks
Potential Plasma Metabolic Biomarkers of Tourette Syndrome Discovery Based on Integrated Non-Targeted and Targeted Metabolomics Screening
Leying Xi, Fuqiong Zhou, Huan Sha, Weina Zhu, Xueling Hu, Jie Ruan, Xueling Hu, Yajie Zhang, Hongyan Long · 2022 · Evidence-based Complementary and Alternative Medicine
Future Perspectives of Metabolomics: Gaps, Planning, and Recommendations
Vijay Soni, Nicholas Bartelo, Annalise Schweickart, Yogesh Chawla, Ankita Dutta, Sonia Jain · 2023 · Springer eBooks
Anthranilic Acid, a GPR109A Agonist, and Schizophrenia
Gregory F. Oxenkrug, Brent P. Forester · 2024 · International Journal of Tryptophan Research
Chronic Olanzapine Treatment Induces Disorders of Plasma Fatty Acid Profile in Balb/c Mice: A Potential Mechanism for Olanzapine-Induced Insulin Resistance
Huqun Li, Maosheng Fang, Mingzhen Xu, Shihong Li, Juan Du, Weiyong Li, Hui Chen · 2016 · PLoS ONE
Medical Needs in the Treatment of Psychotic Disorders
F. Markus Leweke, Thorsten Odorfer, Jan Malte Bumb · 2012 · Handbook of experimental pharmacology
Plasma Metabolite Profiles in First Episode Psychosis: Exploring Symptoms Heterogeneity/Severity in Schizophrenia and Bipolar Disorder Cohorts
Helena Passarelli Giroud Joaquim, Alana C. Costa, Leda Leme Talib, Frederik Dethloff, Maurício Henriques Serpa, Marcus V. Zanetti, Martinus Theodorus van de Bilt, Christoph W. Turck · 2020 · Frontiers in Psychiatry
Metabolomic profiles associated with a mouse model of antipsychotic-induced food intake and weight gain
Rizaldy C. Zapata, Sara Brin Rosenthal, Kathleen M Fisch, Khoi Dao, Mohit Jain, Olivia Osborn · 2020 · Scientific Reports
Lipidomics
Paola Donato, Francesco Cacciola, Marco Beccaria, Paola Dugo, Luigi Mondello · 2015 · Comprehensive analytical chemistry
Atypical Antipsychotics and the Human Skeletal Muscle Lipidome
Kyle Jon Burghardt, Kristen M. Ward, Elani Sanders, Bradley H. Howlett, Berhane Seyoum, Zhengping Yi · 2018 · Metabolites
Metabolomics: A Global Biochemical Approach to the Discovery of Biomarkers for Psychiatric Disorders
Rima Kaddurah‐Daouk, Jair C. Soares, Marlon P. Quinones · 2008 · Springer eBooks
Introduction: Biomarkers in Translational and Personalized Medicine
Chanchal Kumar, Alain J. van Gool · 2013 · Royal Society of Chemistry eBooks
Metabolomic signatures associated with weight gain and psychosis spectrum diagnoses: A pilot study
Jiwon Lee, Kenya A. Costa-Dookhan, Kristoffer J. Panganiban, Nicole E. MacKenzie, Quinn Casuccio Treen, Araba F. Chintoh, Gary J. Remington, Daniel J. Müller, Sanjeev Sockalingam, Philip Gerretsen et al. · 2023 · Frontiers in Psychiatry
Small phenolic and indolic gut-dependent molecules in the primate central nervous system: levels vs. bioactivity
George Eugene Jaskiw, Dongyan Xu, Mark E. Obrenovich, Curtis J. Donskey · 2022 · Metabolomics
Lipid‐correlated alterations in the transcriptome are enriched in several specific pathways in the postmortem prefrontal cortex of Japanese patients with schizophrenia
Wataru Arihisa, Takeshi Kondo, Katsushi Yamaguchi, Junya Matsumoto, Hiroki Nakanishi, Yasuto Kunii, Hiroyasu Akatsu, Mizuki Hino, Yoshio Hashizume, Shumpei Sato et al. · 2023 · Neuropsychopharmacology Reports
Acanthosis Nigricans During Treatment With Aripiprazole
Peter Manu, Zainab Al-Dhaher, Navin Dargani, Christoph Ulrich Correll · 2012 · American Journal of Therapeutics
UPLC-MS-Based Serum Metabolic Profiling Reveals Potential Biomarkers for Predicting Propofol Responsiveness in Females
Ruiyun Li, Lu Yang, Su Guan, Ming‐Tsan Lin, Han-Jin Lai, Kun Liu, Zimeng Liu, Xuyu Zhang · 2021 · Journal of Proteome Research
Blood metabolites, neurocognition and psychiatric disorders: a Mendelian randomization analysis to investigate causal pathways
Jing Guo, Ping Yang, Jiahao Wang, Shi-Hao Tang, Ji-Zhou Han, Shi Yao, Ke Yu, Congcong Liu, Shan‐Shan Dong, Kun Zhang et al. · 2024 · Translational Psychiatry
Metabolomics and Cytokine Analysis for Identification of Schizophrenia with Auditory Hallucination
Xinchun Li, Chao Yang, Xiaoli Liang, Dongfeng Li, Zhiqiang Zhou, Huiqiong Xiao, Xuejun Liu, Li Jie, Dong Liang Yang, Meizhi Li · 2022 · Clinical and investigative medicine
Metabolic biomarkers of risperidone-induced weight gain in drug-naïve patients with schizophrenia
Yuying Qiu, Yeqing Dong, Wei Sun, Gang Li, Mei Juan Li, Yongping Zhao, Changyong Jiang, Jie Li · 2023 · Frontiers in Psychiatry
The identification of novel schizophrenia-related metabolites using untargeted lipidomics
Mengyao Shi, Xiangdong Du, Yiming Jia, Yonghong Zhang, Qiufang Jia, Xiaobin Zhang, Zhengbao Zhu · 2024 · Cerebral Cortex
Modulation of polyunsaturated fatty acid biosynthesis by antipsychotic medications: implications for the pathophysiology and treatment of schizophrenia
Robert K. McNamara · 2009 · Clinical Lipidology
Bayesian semiparametric copula estimation with application to psychiatric genetics
Ori Rosen, Wesley K. Thompson · 2015 · Biometrical Journal
Phospholipids and Insulin Resistance in Psychosis: A Lipidomics Study of Twin Pairs Discordant for Schizophrenia
Orešič, Matej, Seppänen-Laakso, Tuulikki, Sun, Daqiang, Tang, Jing, Therman, Sebastian, Viehman, Rachael, Mustonen, Ulla, van Erp, Theo G, Hyötyläinen, Tuulia, Thompson, Paul et al. · 2012 · Genome Medicine